Top

Published in:

01-11-2006 | Original Article

Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation

Authors: Frederic Triponez, David Dosseh, Marc Hazzan, Christian Noel, Benoit Soudan, Jonathan Lokey, Martha Mozzon, Charles A. G. Proye

Published in: Langenbeck's Archives of Surgery | Issue 6/2006

Abstract

Background and aims

Intra-operative parathyroid hormone (IOPTH) results are not known in the setting of tertiary hyperparathyroidism (HPT) after renal transplantation.

Materials and methods

A retrospective analysis of 35 tertiary HPT patients who all underwent subtotal parathyroidectomy and IOPTH monitoring was conducted.

Results

The mean follow-up time was 2.2±1.4 years. Thirty-four patients were cured; one patient (2.8%) had a persistent disease and was cured after reoperation. Median parathyroid hormone (PTH) (median percent decrease from highest) at baseline and at 5, 10, 20, and 30 min were 244, 78 (69%), 63 (75%), 53 (79%), and 49 pg/ml (83%), respectively. Four patients who were cured had a decrease of <50% at 5 min and two of them had a decrease of <50% at 10 min. The patient with persistent disease had a decrease of >50% at 10 min. The sensitivity of the test was 94% at 10 min using the Miami criteria.

Conclusion

This study shows that IOPTH in tertiary hyperparathyroidism has a high sensitivity. However, because of the low risk of persistent hyperparathyroidism when a subtotal parathyroidectomy is performed, its potential impact on the overall success rate is very small. We therefore do not recommend the routine use of IOPTH in tertiary hyperparathyroidism.

Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15(6):745–750PubMedCrossRef

Kerby JD, Rue LW, Blair H, Hudson S, Sellers MT, Diethelm AG (1998) Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 227(6):878–886PubMedCrossRef

Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y, Numano M, Tanaka Y, Inagaki H, Watanabe I, Hachisuka T, Takagi H (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38(4 Suppl 1):S168–S171PubMed

Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E, Mullineris B, Dei Poli M (2001) Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233(1):65–69PubMedCrossRef

Sancho JJ, Sitges-Serra A (1997) Surgical approach to secondary hyperparathyroidism. In: Clark OH, Duh QY (eds) Textbook of endocrine surgery, vol 50. Saunders, San Francisco, pp 403–409

Kebebew E, Duh QY, Clark OH (2004) Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Arch Surg 139(9):974–977PubMedCrossRef

Triponez F, Dosseh D, Hazzan M, Noel C, Vanhille P, Proye CA (2005) Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg 92(10):1282–1287PubMedCrossRef

Nichol PF, Starling JR, Mack E, Klovning JJ, Becker BN, Chen H (2002) Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 235(5):673–678PubMedCrossRef

Nichol PF, Mack E, Bianco J, Hayman A, Starling JR, Chen H (2003) Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery 134(4):713–717PubMedCrossRef

10.

Kilgo MS, Pirsch JD, Warner TF, Starling JR (1998) Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery 124(4):677–683PubMedCrossRef

11.

Cintin C, Karstrup S, Ladefoged SD, Joffe P (1994) Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection. Nephron 68(2):217–220PubMedCrossRef

12.

Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA (1988) Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 104(6):1121–1127PubMed

13.

Irvin GL 3rd, Deriso GT 3rd (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168(5):466–468PubMedCrossRef

14.

Johnson LR, Doherty G, Lairmore T, Moley JF, Brunt LM, Koenig J, Scott MG (2001) Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem 47(5):919–925PubMed

15.

Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235(5):665–670PubMedCrossRef

16.

Fahy BN, Bold RJ, Beckett L, Schneider PD (2002) Modern parathyroid surgery: a cost–benefit analysis of localizing strategies. Arch Surg 137(8):917–922PubMedCrossRef

17.

Westerdahl J, Bergenfelz A (2004) Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg 28(11):1132–1138PubMedCrossRef

18.

Lokey J, Pattou F, Mondragon-Sanchez A, Minuto M, Mullineris B, Wambergue F, Foissac-Geroux P, Noel C, de Sagazan HL, VanHille P, Proye CA (2000) Intraoperative decay profile of intact (1–84) parathyroid hormone in surgery for renal hyperparathyroidism—a consecutive series of 80 patients. Surgery 128(6):1029–1034PubMedCrossRef

19.

Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM (2002) Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 137(3):341–344PubMedCrossRef

20.

Seehofer D, Rayes N, Klupp J, Steinmuller T, Ulrich F, Muller C, Schindler R, Frei U, Neuhaus P (2005) Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism. Langenbecks Arch Surg 390(3):222–229PubMedCrossRef

21.

Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D’Amour P (1998) A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44(4):805–809PubMed

22.

National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):1–201

23.

Krause MW, Hedinger CE (1985) Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol 16(8):772–784PubMedCrossRef

24.

Libutti SK, Alexander HR, Bartlett DL, Sampson ML, Ruddel ME, Skarulis M, Marx SJ, Spiegel AM, Simmonds W, Remaley AT (1996) Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery 126(6):1145–1150

25.

Kaczirek K, Riss P, Wunderer G, Prager G, Asari R, Scheuba C, Bieglmayer C, Niederle B (2005) Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery 137(4):431–435PubMedCrossRef

26.

Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle JC (2005) Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 90(12):6370–6372PubMedCrossRef

27.

Lorenz K, Dralle H (2005) Will intra-operative measurement of parathyroid hormone alter the surgical concept of renal hyperparathyroidism? Langenbecks Arch Surg 390(4):277–279PubMedCrossRef

28.

Haustein SV, Mack E, Starling JR, Chen H (2005) The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 138(6):1066–1071PubMedCrossRef

29.

US Renal Data System (USRDS) (2004) Annual data report: atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD

30.

Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B (2006) Novel parathyroid hormone (1–84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Arch Surg 141(2):129–134PubMedCrossRef

31.

Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H, Fukagawa M (2004) Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery 135(2):149–156PubMedCrossRef

Title: Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation
Authors: Frederic Triponez
David Dosseh
Marc Hazzan
Christian Noel
Benoit Soudan
Jonathan Lokey
Martha Mozzon
Charles A. G. Proye
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Langenbeck's Archives of Surgery / Issue 6/2006
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-006-0070-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation

Abstract

Background and aims

Materials and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background and aims

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2006

Supervised surgical trainees perform thyroid surgery for Graves’ disease safely

Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors—a novel antiproliferative/antiangiogenic strategy in thyroid cancer

Inadvertent parathyroidectomy during thyroid surgery: the incidence of a complication of thyroidectomy

Clinical outcome of different modes of resection in papillary thyroid carcinomas with laryngotracheal invasion

Optimizing preoperative imaging in primary hyperparathyroidism

Cigarette smoking: cancer risks, carcinogens, and mechanisms